Evolution of left ventricular ejection fraction after acute myocardial infarction: implications for implantable...

Area of Science:

• Cardiology
• Cardiac Electrophysiology

Background:

• Implantable cardioverter-defibrillator (ICD) therapy is vital for survival in acute myocardial infarction (AMI) patients with reduced left ventricular ejection fraction (LVEF).
• Optimal timing for ICD implantation post-AMI remains undetermined, despite the highest risk of sudden cardiac death occurring within the first month.

Purpose of the Study:

• To determine the proportion of post-AMI patients with sufficient left ventricular (LV) function recovery to potentially obviate the need for an ICD.
• To assess the time course of LV function improvement after AMI.

Main Methods:

• Prospective study including 100 patients admitted for AMI with LVEF ≤40%.
• Echocardiographic assessments of LVEF were performed at 5 days, 1 month, and 3 months post-AMI.
• Monitoring for life-threatening arrhythmias during the first 9 weeks.

Main Results:

• Initial LVEF was 31±5.8%.
• By 1 month post-AMI, 55% of patients achieved an LVEF >35%, with most significant improvement noted by this time point.
• Further LVEF improvement between 1 and 3 months was minimal (mean difference 1.9 percentage units).
• 10% of patients experienced life-threatening arrhythmias within the first 9 weeks.

Conclusions:

• Significant LVEF recovery is common in post-AMI patients, often evident by the 1-month follow-up.
• Delaying ICD implantation beyond 1 month may not be warranted for many patients due to established functional recovery.
• The 10% incidence of serious arrhythmias highlights the persistent risk of sudden cardiac death in this patient cohort.